X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (50) 50
multiple myeloma (47) 47
female (41) 41
index medicus (40) 40
middle aged (39) 39
aged (38) 38
male (38) 38
bortezomib (33) 33
multiple myeloma - drug therapy (31) 31
hematology (29) 29
aged, 80 and over (24) 24
antineoplastic combined chemotherapy protocols - therapeutic use (24) 24
adult (23) 23
multiple myeloma - mortality (20) 20
survival (19) 19
dexamethasone (18) 18
oncology (17) 17
antineoplastic combined chemotherapy protocols - adverse effects (13) 13
disease-free survival (13) 13
stem-cell transplantation (13) 13
thalidomide - administration & dosage (13) 13
treatment outcome (13) 13
dexamethasone - administration & dosage (12) 12
recurrence (12) 12
therapy (12) 12
analysis (11) 11
boronic acids - administration & dosage (11) 11
pyrazines - administration & dosage (11) 11
transplantation (11) 11
kaplan-meier estimate (10) 10
melphalan - administration & dosage (10) 10
patients (10) 10
abridged index medicus (9) 9
diagnosis (9) 9
multiple myeloma - pathology (9) 9
prednisone - administration & dosage (9) 9
trial (9) 9
antineoplastic combined chemotherapy protocols - administration & dosage (8) 8
chemotherapy (8) 8
follow-up studies (8) 8
lenalidomide (8) 8
medicine, general & internal (8) 8
melphalan (8) 8
prednisone (8) 8
risk assessment (8) 8
thalidomide - analogs & derivatives (8) 8
care and treatment (7) 7
clinical trials (7) 7
drug administration schedule (7) 7
neoplasm staging (7) 7
stem cell transplantation (7) 7
stem cells (7) 7
survival analysis (7) 7
survival rate (7) 7
thalidomide (7) 7
abnormalities (6) 6
cytogenetics (6) 6
hematology, oncology and palliative medicine (6) 6
overall survival (6) 6
peripheral neuropathy (6) 6
risk factors (6) 6
dexamethasone - adverse effects (5) 5
disease progression (5) 5
drug therapy (5) 5
immunology (5) 5
initial treatment (5) 5
melphalan - adverse effects (5) 5
monoclonal antibodies (5) 5
multiple myeloma - therapy (5) 5
prognosis (5) 5
retrospective studies (5) 5
thalidomide - adverse effects (5) 5
age (4) 4
autografts (4) 4
bone marrow (4) 4
boronic acids - adverse effects (4) 4
bortezomib - administration & dosage (4) 4
cancer (4) 4
carfilzomib (4) 4
cells (4) 4
chromosome aberrations (4) 4
combination (4) 4
cyclophosphamide - administration & dosage (4) 4
dosage and administration (4) 4
drug dosages (4) 4
efficacy (4) 4
elderly-patients (4) 4
hematopoietic stem cell transplantation (4) 4
incidence (4) 4
induction chemotherapy (4) 4
interleukin-6 (4) 4
low-dose dexamethasone (4) 4
malignancy (4) 4
medicine, research & experimental (4) 4
multiple myeloma - complications (4) 4
multiple myeloma - diagnosis (4) 4
multiple-myeloma (4) 4
neutropenia (4) 4
oligopeptides - administration & dosage (4) 4
open-label (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 01/2015, Volume 372, Issue 2, pp. 142 - 152
Journal Article
British Journal of Haematology, ISSN 0007-1048, 05/2017, Volume 177, Issue 3, pp. 404 - 413
Journal Article
American Journal of Hematology, ISSN 0361-8609, 01/2015, Volume 90, Issue 1, pp. 42 - 49
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2015, Volume 373, Issue 7, pp. 621 - 631
Journal Article
European Journal of Haematology, ISSN 0902-4441, 07/2017, Volume 99, Issue 1, pp. 80 - 90
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2012, Volume 366, Issue 19, pp. 1759 - 1769
Journal Article
Journal Article
Computational and Structural Biotechnology Journal, ISSN 2001-0370, 06/2014, Volume 10, Issue 16, pp. 38 - 40
Multiple myeloma (MM) is a clonal B-cell malignancy characterized by aberrant expansion of plasma cells within bone marrow and extramedullary sites. It is one... 
Bortezomib | Lenalidomide | ASCT | Multiple myeloma
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2008, Volume 359, Issue 9, pp. 906 - 917
Journal Article